WO1994008030A1 - PROCESS FOR PRODUCING D-α-AMINO ACID - Google Patents
PROCESS FOR PRODUCING D-α-AMINO ACID Download PDFInfo
- Publication number
- WO1994008030A1 WO1994008030A1 PCT/JP1993/001408 JP9301408W WO9408030A1 WO 1994008030 A1 WO1994008030 A1 WO 1994008030A1 JP 9301408 W JP9301408 W JP 9301408W WO 9408030 A1 WO9408030 A1 WO 9408030A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- decarbamylase
- ala
- amino acid
- enzyme
- arg
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 26
- 150000007650 D alpha amino acids Chemical class 0.000 title claims abstract description 9
- 102000004190 Enzymes Human genes 0.000 claims abstract description 52
- 108090000790 Enzymes Proteins 0.000 claims abstract description 52
- 244000005700 microbiome Species 0.000 claims abstract description 26
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 12
- 241000586490 Blastobacter Species 0.000 claims abstract description 7
- 241000589519 Comamonas Species 0.000 claims abstract description 6
- 239000012736 aqueous medium Substances 0.000 claims abstract description 6
- 241000589180 Rhizobium Species 0.000 claims abstract description 5
- 241000186063 Arthrobacter Species 0.000 claims abstract description 4
- 241000589173 Bradyrhizobium Species 0.000 claims abstract description 4
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 4
- 238000004519 manufacturing process Methods 0.000 claims description 30
- 241001478312 Comamonas sp. Species 0.000 claims description 24
- 239000002609 medium Substances 0.000 claims description 22
- 239000002253 acid Substances 0.000 claims description 19
- 150000001413 amino acids Chemical class 0.000 claims description 17
- 239000004289 sodium hydrogen sulphite Substances 0.000 claims description 15
- 150000008574 D-amino acids Chemical class 0.000 claims description 10
- 239000000126 substance Substances 0.000 claims description 10
- 229910052700 potassium Inorganic materials 0.000 claims description 9
- 239000011591 potassium Substances 0.000 claims description 9
- 239000000284 extract Substances 0.000 claims description 8
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 8
- XSQUKJJJFZCRTK-UHFFFAOYSA-N urea group Chemical group NC(=O)N XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 7
- OIVLITBTBDPEFK-UHFFFAOYSA-N 5,6-dihydrouracil Chemical compound O=C1CCNC(=O)N1 OIVLITBTBDPEFK-UHFFFAOYSA-N 0.000 claims description 6
- 229910021645 metal ion Inorganic materials 0.000 claims description 6
- 239000004402 sodium ethyl p-hydroxybenzoate Substances 0.000 claims description 5
- 241000588986 Alcaligenes Species 0.000 claims description 4
- ZGUNAGUHMKGQNY-SSDOTTSWSA-N D-alpha-phenylglycine Chemical compound OC(=O)[C@H](N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-SSDOTTSWSA-N 0.000 claims description 4
- 241000589187 Rhizobium sp. Species 0.000 claims description 4
- 239000004202 carbamide Substances 0.000 claims description 4
- 150000001469 hydantoins Chemical class 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 230000002708 enhancing effect Effects 0.000 claims description 3
- 229940091173 hydantoin Drugs 0.000 claims description 3
- 239000004470 DL Methionine Substances 0.000 claims description 2
- 108010093096 Immobilized Enzymes Proteins 0.000 claims description 2
- 239000003623 enhancer Substances 0.000 claims description 2
- 108010089804 glycyl-threonine Proteins 0.000 claims description 2
- 150000003230 pyrimidines Chemical class 0.000 claims description 2
- 241000589174 Bradyrhizobium japonicum Species 0.000 claims 1
- 241001162968 Sarsina Species 0.000 claims 1
- 241000186547 Sporosarcina Species 0.000 abstract description 3
- 230000007935 neutral effect Effects 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
- 229940088598 enzyme Drugs 0.000 description 44
- 238000006243 chemical reaction Methods 0.000 description 39
- 230000000694 effects Effects 0.000 description 31
- 239000000243 solution Substances 0.000 description 30
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 19
- 150000001875 compounds Chemical class 0.000 description 13
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 12
- 239000008103 glucose Substances 0.000 description 12
- 239000008057 potassium phosphate buffer Substances 0.000 description 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- 235000001014 amino acid Nutrition 0.000 description 10
- 238000005119 centrifugation Methods 0.000 description 9
- 230000012010 growth Effects 0.000 description 9
- 239000011780 sodium chloride Substances 0.000 description 9
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 8
- 229910052799 carbon Inorganic materials 0.000 description 8
- 235000018102 proteins Nutrition 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 238000000746 purification Methods 0.000 description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 239000000758 substrate Substances 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 102000004316 Oxidoreductases Human genes 0.000 description 6
- 108090000854 Oxidoreductases Proteins 0.000 description 6
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 229940041514 candida albicans extract Drugs 0.000 description 6
- 238000002523 gelfiltration Methods 0.000 description 6
- 230000007062 hydrolysis Effects 0.000 description 6
- 238000006460 hydrolysis reaction Methods 0.000 description 6
- 230000006799 invasive growth in response to glucose limitation Effects 0.000 description 6
- 230000000877 morphologic effect Effects 0.000 description 6
- 230000001766 physiological effect Effects 0.000 description 6
- 239000012138 yeast extract Substances 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 229920005654 Sephadex Polymers 0.000 description 5
- 239000012507 Sephadex™ Substances 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 102000016938 Catalase Human genes 0.000 description 4
- 108010053835 Catalase Proteins 0.000 description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000004471 Glycine Substances 0.000 description 4
- 229930195725 Mannitol Natural products 0.000 description 4
- -1 N-Acetyl glucosan Chemical compound 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 238000012870 ammonium sulfate precipitation Methods 0.000 description 4
- 239000007853 buffer solution Substances 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 239000000594 mannitol Substances 0.000 description 4
- 235000010355 mannitol Nutrition 0.000 description 4
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 4
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 3
- 239000004475 Arginine Substances 0.000 description 3
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 3
- COLNVLDHVKWLRT-MRVPVSSYSA-N D-phenylalanine Chemical compound OC(=O)[C@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-MRVPVSSYSA-N 0.000 description 3
- 229930182832 D-phenylalanine Natural products 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- ZOCYQVNGROEVLU-UHFFFAOYSA-N Isopentadecylic acid Natural products CC(C)CCCCCCCCCCCC(O)=O ZOCYQVNGROEVLU-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 3
- 241000233855 Orchidaceae Species 0.000 description 3
- 229920002684 Sepharose Polymers 0.000 description 3
- IPBVNPXQWQGGJP-UHFFFAOYSA-N acetic acid phenyl ester Natural products CC(=O)OC1=CC=CC=C1 IPBVNPXQWQGGJP-UHFFFAOYSA-N 0.000 description 3
- 239000001361 adipic acid Substances 0.000 description 3
- 235000011037 adipic acid Nutrition 0.000 description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 3
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 3
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 3
- 235000011130 ammonium sulphate Nutrition 0.000 description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
- 239000013592 cell lysate Substances 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 239000001630 malic acid Substances 0.000 description 3
- 235000011090 malic acid Nutrition 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 229940049953 phenylacetate Drugs 0.000 description 3
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 3
- 229920002401 polyacrylamide Polymers 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 238000004809 thin layer chromatography Methods 0.000 description 3
- 238000000108 ultra-filtration Methods 0.000 description 3
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
- XKLJLHAPJBUBNL-UHFFFAOYSA-N 12-methyltetradecanoic acid Chemical compound CCC(C)CCCCCCCCCCC(O)=O XKLJLHAPJBUBNL-UHFFFAOYSA-N 0.000 description 2
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N 4-aminoantipyrine Chemical compound CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 description 2
- VMAQYKGITHDWKL-UHFFFAOYSA-N 5-methylimidazolidine-2,4-dione Chemical compound CC1NC(=O)NC1=O VMAQYKGITHDWKL-UHFFFAOYSA-N 0.000 description 2
- NXQJDVBMMRCKQG-UHFFFAOYSA-N 5-phenylimidazolidine-2,4-dione Chemical compound O=C1NC(=O)NC1C1=CC=CC=C1 NXQJDVBMMRCKQG-UHFFFAOYSA-N 0.000 description 2
- 241000588810 Alcaligenes sp. Species 0.000 description 2
- 241000304886 Bacilli Species 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 102000000634 Cytochrome c oxidase subunit IV Human genes 0.000 description 2
- 108050008072 Cytochrome c oxidase subunit IV Proteins 0.000 description 2
- QNAYBMKLOCPYGJ-UWTATZPHSA-N D-alanine Chemical compound C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 2
- 108090000604 Hydrolases Proteins 0.000 description 2
- 102000004157 Hydrolases Human genes 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 239000003456 ion exchange resin Substances 0.000 description 2
- 229920003303 ion-exchange polymer Polymers 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000003472 neutralizing effect Effects 0.000 description 2
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- AUTALUGDOGWPQH-SPWJBRMPSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;(2s,3r,4r)-2,3,4,5-tetrahydroxypentanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O AUTALUGDOGWPQH-SPWJBRMPSA-N 0.000 description 1
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- FTNJQNQLEGKTGD-UHFFFAOYSA-N 1,3-benzodioxole Chemical compound C1=CC=C2OCOC2=C1 FTNJQNQLEGKTGD-UHFFFAOYSA-N 0.000 description 1
- KZMFYTYCSRZEDR-UHFFFAOYSA-N 1-phenylperylene Chemical group C1=CC=CC=C1C1=CC=C(C=CC=C23)C2=C1C1=C2C3=CC=CC2=CC=C1 KZMFYTYCSRZEDR-UHFFFAOYSA-N 0.000 description 1
- ZONJATNKKGGVSU-UHFFFAOYSA-N 14-methylpentadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCC(O)=O ZONJATNKKGGVSU-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- LJCWONGJFPCTTL-UHFFFAOYSA-N 4-hydroxyphenylglycine Chemical compound OC(=O)C(N)C1=CC=C(O)C=C1 LJCWONGJFPCTTL-UHFFFAOYSA-N 0.000 description 1
- UMTNMIARZPDSDI-UHFFFAOYSA-N 5-(4-hydroxyphenyl)imidazolidine-2,4-dione Chemical compound C1=CC(O)=CC=C1C1C(=O)NC(=O)N1 UMTNMIARZPDSDI-UHFFFAOYSA-N 0.000 description 1
- 241001453369 Achromobacter denitrificans Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 240000003291 Armoracia rusticana Species 0.000 description 1
- 235000011330 Armoracia rusticana Nutrition 0.000 description 1
- 102100026189 Beta-galactosidase Human genes 0.000 description 1
- 241000589171 Bradyrhizobium sp. Species 0.000 description 1
- FXUKWLSZZHVEJD-UHFFFAOYSA-N C16:0-14-methyl Natural products CCC(C)CCCCCCCCCCCCC(O)=O FXUKWLSZZHVEJD-UHFFFAOYSA-N 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 102000018832 Cytochromes Human genes 0.000 description 1
- 108010052832 Cytochromes Proteins 0.000 description 1
- LJCWONGJFPCTTL-SSDOTTSWSA-N D-4-hydroxyphenylglycine Chemical compound [O-]C(=O)[C@H]([NH3+])C1=CC=C(O)C=C1 LJCWONGJFPCTTL-SSDOTTSWSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UWTATZPHSA-N D-Serine Chemical compound OC[C@@H](N)C(O)=O MTCFGRXMJLQNBG-UWTATZPHSA-N 0.000 description 1
- 229930195711 D-Serine Natural products 0.000 description 1
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 1
- 102100026908 D-amino-acid oxidase Human genes 0.000 description 1
- 108010003989 D-amino-acid oxidase Proteins 0.000 description 1
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 1
- 102100036238 Dihydropyrimidinase Human genes 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 1
- 235000019766 L-Lysine Nutrition 0.000 description 1
- HGNRJCINZYHNOU-LURJTMIESA-N Lys-Gly Chemical compound NCCCC[C@H](N)C(=O)NCC(O)=O HGNRJCINZYHNOU-LURJTMIESA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241001135320 Mesorhizobium huakuii Species 0.000 description 1
- 241000589195 Mesorhizobium loti Species 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- JSJWCHRYRHKBBW-UHFFFAOYSA-N N-carbamoyl-beta-alanine Chemical compound NC(=O)NCCC(O)=O JSJWCHRYRHKBBW-UHFFFAOYSA-N 0.000 description 1
- 241000589125 Neorhizobium galegae Species 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 108010013639 Peptidoglycan Proteins 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 102000007327 Protamines Human genes 0.000 description 1
- 108010007568 Protamines Proteins 0.000 description 1
- 244000184734 Pyrus japonica Species 0.000 description 1
- 239000012506 Sephacryl® Substances 0.000 description 1
- 241000589166 Sinorhizobium fredii Species 0.000 description 1
- 241000589196 Sinorhizobium meliloti Species 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 241000246348 Sporosarcina sp. Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- JCFADYTWTKDWKU-UHFFFAOYSA-N acetic acid;hydrochloride Chemical compound Cl.CC(O)=O.CC(O)=O JCFADYTWTKDWKU-UHFFFAOYSA-N 0.000 description 1
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- SKKTUOZKZKCGTB-UHFFFAOYSA-N butyl carbamate Chemical compound CCCCOC(N)=O SKKTUOZKZKCGTB-UHFFFAOYSA-N 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 108091022884 dihydropyrimidinase Proteins 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000007986 glycine-NaOH buffer Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000004464 hydroxyphenyl group Chemical group 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000005524 levulinyl group Chemical group 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 108010064235 lysylglycine Proteins 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 239000012450 pharmaceutical intermediate Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229950008679 protamine sulfate Drugs 0.000 description 1
- 238000011403 purification operation Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12P41/006—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures
- C12P41/009—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures by reactions involving hydantoins or carbamoylamino compounds
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/874—Pseudomonas
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/911—Microorganisms using fungi
Definitions
- the present invention has the general formula:
- R phenyl group substituted phenyl group, a hydroxyl group, a substituted or unsubstituted, preferably an alkyl group or Choi two Le group having 1 to 5 carbon atoms
- decarbamylase An enzyme having the ability to remove a levulinyl group (hereinafter referred to as "decarbamylase”) is acted on a DN-amino acid represented by the general formula:
- Such optically active D-monoamino acids are important compounds as pharmaceutical intermediates, and in particular, D-phenylglycine and D- (4- (4) -intermediate during the production of semisynthetic penicillin and semisynthetic cephalosporin.
- Hydroxyphenyl) glycine hereinafter referred to as “D-HPGJ”) and the like are mentioned as industrially useful compounds.
- D-HPGJ Hydroxyphenyl) glycine
- a method for producing D- ⁇ -amino acids there is known a method for obtaining the D- ⁇ -amino acid by removing the corresponding L-amino acid-lebamil group.
- the removal of the substance can be carried out by a chemical method (see Japanese Patent Publication No. 58-4707) or a method using an enzymatic reaction of a microorganism (Japanese Patent Publication No. 57-18793, Japanese Patent Publication No. No. 0250 and Japanese Patent Publication No. Hei 11-48757).
- D The DL-5-substituted hydantoin corresponding to one amino acid is selectively hydrolyzed to the D-form by the action of an enzyme to obtain ⁇ -force rubamyl-D- ⁇ -amino acid, followed by the action of decarbamylase
- the optimal ⁇ of the first-stage hydantoin hydrolase was in ⁇ 8-9, so it was necessary to perform the reaction in a different reaction system from the second-stage decarbamylase.
- the inventors of the present invention act on DN-potassium amino acids to enzymatically remove them and convert them to D- ⁇ -amino acids (hereinafter, referred to as “depotted rubamyl”).
- depotted rubamyl D- ⁇ -amino acids
- the present invention provides a compound represented by the general formula (I): R-CH-COOH
- R represents a phenyl group, a phenyl group substituted with a hydroxyl group, a substituted or unsubstituted alkyl group having preferably 1 to 5 carbon atoms, or a phenyl group.
- an enzyme produced by microorganisms is allowed to act on N-potassium
- Enzymes that convert N-potassium-D-one amino acid to D-one amino acid As decarbamylase, the genus Comamonas, the genus Blastobacter, the genus Alcaligenes, the genus Sporosarcina, and the lysozyme
- the present invention provides a method for producing a D- ⁇ -amino acid, which comprises using an enzyme that can be produced by a microorganism belonging to the genus (Rhizobium), the genus Bradyrhizobium or the genus Arthrobacter.
- FIG. 1 is a graph showing the results of the weakened lubamil reaction at 50 ° C. and 30 ° C. of the strains obtained by the new screening.
- FIG. 2 is a graph showing the effect of a compound added during the culture of Comamonas sp. E222C on the production of decarbamylase.
- FIG. 3 shows the results of analyzing the purified decarbamylase of Comamonas sp. E222C by SDS-polyacrylamide gel electrophoresis.
- Fig. 4 is a graph showing the results of gel filtration of purified decarbamylase of Comamonas sp. E222C using a Sephadex G-150 column.
- Figure 5 is a graph showing the results of examining the effect of anti-latency time of P H using Comamonas sp. E 2 2 2 C purification decarbamylase.
- FIG. 6 is a graph showing the results of examining the effect of temperature during the reaction using purified decarbamylase of Comamonas sp. E222C.
- FIG. 7 is a graph showing the effect of a compound added during the culturing of Blastpactor sp. A17 p-4 on decarbamylase production.
- FIG. 8 is a graph showing the effect of metal ions added during the cultivation of blast pacter sp. A17 p-4 on decarbamylase production.
- FIG. 9 shows the results of analyzing the purified decarbamylase of Blastpactor sp. A17 p-4 by SDS-polyacrylamide gel electrophoresis.
- FIG. 10 is a graph showing the results of gel filtration of blastpacter sp. A17p-4 purified decarbamylase using a Sephadex G-150 column.
- FIG. 11 is a graph showing the results of examining the effect of pH during the reaction using blastpacter sp. A17p-4 purified decarbamylase.
- FIG. 12 is a graph showing the results of examining the effect of temperature during the reaction using blastpacter sp. A17p-4 purified decarbamylase.
- the decarbamylase used in the present invention may be one that specifically acts on the D-isomer or an enzyme that acts on either the D-isomer or the L-body.
- An enzyme with severe stereoselectivity for DN-l-rubamyl-amino acid is sometimes called DN-l-rubamyl-unique amino acid amide hydrolase.
- the orchid strains having relatively high weakened lubamil activity include Comamonas sp. E 222 C (FERM BP No. 4411, Ministry of International Trade and Industry, Institute of Biotechnology, Institute of Biotechnology, Tsukuba, Ibaraki, Japan) Ichihigashi 1-chome 1-3 (zip code 305), September 18, 1992), Comamonas sp. E 206a, Comamonas sp. E 217a, Blastpactor sp. NA88—b, Blastpactor sp. Al 7p- 4 (FERM BP No.
- NCA28-b Rhizobium sp. KNK1415
- Arslobacta-sp. CA17-2 The bacteriological properties of NCA28-b, Rhizobium sp. KNK1415 and Arslobacta-sp. CA17-2 are shown below.
- Colony morphology pale yellow, slightly translucent, round, regular, round-low convex, shiny, smooth, lmm (48 hr) in diameter
- Colony morphology Slightly yellowish white, dull, perfectly round.
- Colony morphology Slightly yellowish white, matte, round, uniform, convex, smooth, about 0.5 strokes in diameter (2 days)
- D-amino acids such as D-p-hydroxyphenylglycine and D-phenylglycine; N-force rubamyl-DL-methionine; N-force rubamyl-D-phenylamine; N-force rubamyl-amino acids such as D-phenylalanine 5-substituted hydantoins such as DL-5-p-hydroxyphenylhydantoin and DL-5-phenylhydantoin; pyrimidine metabolites such as peracyl, dihydrouracil, and y5-ureidopropionic acid; Fe2 + , Fe It is preferable to add a small amount of metal ions such as 3+ , Be 2+ , Co 2+ , Al 3+ , Li +, Mn 2+ , Mg 2 ⁇ Cs +; urea, etc. to enhance and accumulate decarbamylase.
- concentration of these decarbamylase production enhancing substances in the medium is selected from the range
- the temperature during cultivation is in the range of 20 to 85 ° C, and the pH is in the range of 4 to 11, and the growth of microorganisms can be promoted by aeration and stirring.
- the culture solution, cells or treated cells of the microorganism can be obtained as described above.
- the cells can be used as they are, of course, but they can be used as dried cells such as freeze-dried cells, cell lysates or cell extracts, surfactants or ultrasonics.
- the treated bacterial cell can be used as a microbial enzyme source in the reaction of the present invention.
- the enzyme can be used in the form of an enzyme obtained by purifying or partially purifying an enzyme from a crushed product, an extract or a processed product of these cells, or a crude enzyme.
- these enzymes or crude enzymes can be immobilized and used as immobilized enzymes.
- the immobilization method for example, the immobilization method of International Patent Application PCT / JP91 / 01696 can be used.
- enzymes produced from these microorganisms by genetic manipulation are basically equivalent to the enzymes that can be produced by the microorganism.
- the weakened lubamil reaction is carried out in an aqueous medium, and its pH is used in the range of 6 to 11, and particularly preferably pH 7 to 9.5. In addition, some enzymes have an optimal pH between pH 8-9.
- the temperature of the weakened lubamil reaction is usually in the range of 20 to 85 ° C, but a temperature suitable for the enzyme system of the strain to be used is adopted.
- examples of the N-potassium-rubamyl-D-monoamino acid compound serving as a substrate for decarbamylase include DN-potassium-rubamylalanine, DN-potassium-rubamylmethionine, DN-potassium-rubamylparin, — N—potassium luleucine, D—N—potassium lysylglycine, D—N—potassium mono (4-hydroxyphenyl) glycine, D—N—potassium lubamil-1- (2-phenyl) glycine, D — N-potassium rubamylphenylalanine and the like.
- —R in the general formula in the case of a substituted alkyl group, includes a phenyl group, an indolyl group, an alkylthio group, a hydroxyl group, an amino group, a carboxyl group, and the like.
- D produced by the weakened lubamil reaction by microbial enzymes as described above
- the isolation of the amino acids can be performed by a known method such as concentration, neutralization, and treatment with an ion exchange resin. That is, in the case of relatively hydrophobic D-amino acids such as D-fuunyl glycine, D- (4-hydroxyphenol) glycine, D-mouth isine and D-phenylalanine, acidic Alternatively, the desired D-amino acid can be obtained as a precipitate by removing the insolubles in the form of alcohol and concentrating and neutralizing.
- the target substance is adsorbed by ion exchange resin, and this is eluted with ammonia water and the like.
- the desired product can be obtained by neutralizing and concentrating.
- the N-potassium-rubamyl-D-amino acid compound serving as a substrate for these decarbamylases can be obtained by converting a culture solution of microorganisms of various species, bacterial cells, a processed bacterial cell, or an enzyme extracted from the bacterial cells into 5-substituted hydantoins. And can be manufactured.
- Such a manufacturing method is disclosed in Japanese Patent Application Laid-Open Nos. Sho 53-44690, Sho 53-69884, Sho 53-911189, and This is described in Japanese Unexamined Patent Application Publication No. Sho 533-133868, Japanese Patent Application Laid-Open No. 54-84086, Japanese Patent Application Laid-Open No. 55-701, and the like.
- D-potamyl monoamino acids are converted to the corresponding bioactive D-amino acids by the method of the present invention.
- Soil sample the (collecting place names collected from various parts of Japan), the medium of 2ml A (lg / 1 KH 2 P0 4, lg / 1 K 2 HP0 4, 0. 3gZl MgS_ ⁇ 4 ⁇ 7H 2 0, 0. lgZl yeast extract , NH 4 C1, the compounds described below using as a 1. 5 g / l carbon source (PH7. 0)), or medium B (lgZl KH 2 P0 4, lg / 1 K2HPO4. 0. 3 / l MgS0 4 ' 7H 2 0, 0. 5g / l glucose, 0.1 yeast extract, 1. compounds of the mounting serial below used as 5gZl nitrogen source (PH7.
- Comamonas sp. E 222 C was used at 28 ° C using the medium C described in Example 2.
- the blast pacter sp. Al 7 P-4 was cultured with shaking for 1 day or 7 days. Centrifuge 3 ml of the culture solution, suspend the cells in 300 1 reaction solution (200 mM potassium phosphate buffer solution, 1% (WZV) of various reaction substrates), and incubate at 30 with Comamonas sp. The reaction was performed at 50 ° C. for 24 hours with Blastpactor sp. A 17 P-4.
- both cells showed strong hydrolytic activity of aliphatic and aromatic D-amino acids against N-terminal rubamil, but N-terminal rubamil of amino acid having a polar group. Activity was low.
- Comamonas sp. E 222 C was able to hydrolyze yS-peridopropionic acid, and Blastobacter -sp.
- a 17 P-4 also showed hydantoinase activity.
- Medium is a nutrient medium D (lg / 1 KH 2 P0 4, lgZl K 2 HP0 4, 0. 3g / l MgS0 4 * 7H 2 0, 3gZl yeast extract, 3GZl meat extract, 1 Og / 1 glycerol, 2GZl polypeptone ( PH7.0)), the compound shown in Fig. 2 was added at a concentration of 0.15% (w / v), and the bacteria were inoculated and cultured with shaking at 28 ° C for 2 days.
- D a nutrient medium D (lg / 1 KH 2 P0 4, lgZl K 2 HP0 4, 0. 3g / l MgS0 4 * 7H 2 0, 3gZl yeast extract, 3GZl meat extract, 1 Og / 1 glycerol, 2GZl polypeptone ( PH7.0)
- Comamonas sp. E 222C was cultured at 28 ° C in the medium D described in Example 4 supplemented with 5-ureidopropionic acid (0.15% (wZv)) for 3 days to give a total of 3.61
- the cells were suspended in 100 ml of 10 mM potassium phosphate buffer (pH 7.0), disrupted by ultrasonication, and the residue was removed by centrifugation. While adding ammonium sulfate to the crude enzyme solution, the ammonium sulfate precipitation fraction at a concentration of 20% to 40% of the saturation concentration was separated by centrifugation and dissolved in the above buffer solution.
- This concentrated solution (5 ml) was subjected to gel filtration using the Sephacryl S-200 HR column (01.8 x 80 cm) in the above buffer containing 0.2 M NaCl, and the active fraction was desalted by dialysis. After that, adsorb to hydroxyapatite column (01.2 x 10 cm), and use 0 ⁇ 1M potassium phosphate buffer.
- the active fraction (8.5 ml) was dialyzed for 12 hours against 500 ml of a 10 mM potassium phosphate buffer (pH 7.0) for elution with a linear concentration gradient of (pH 7.0). This was adsorbed to a Mono Q HR 5Z5 column, eluted with a linear concentration gradient of 0 to 1.0 M NaCl, and this active fraction (1.2 ml) was used as a purified enzyme solution for analysis.
- the reaction optimum pH was measured by the following method.
- a buffer concentration: 20 OmM
- the quantification of the produced D-phenylalanine was performed using 20 OmM potassium phosphate buffer solution (pH 7.0), 1.5 mM 4-aminoantipyrine, 2. ImM phenol, 2.25 u peroxidase (from horseradish, Calzam ').
- One part of the above enzyme reaction solution was added to a reaction solution containing a laboratory (manufactured by CALZYME Lab.) And 0.375 units of D-amino acid oxidase (manufactured by Sigma) (final volume: 500 ⁇ 1).
- the reaction was carried out at 37 ° C. for 60 minutes and the increase in absorbance at 50 Onm was measured.
- the optimum reaction temperature is the same as the above using a potassium phosphate buffer solution (pH 7.0), and the reaction is performed at 10 ° C to 80 ° C for 20 minutes. Phenol method [Bollter, WT Et al., Analytical Chemistry, Vol. 33, 592-594 (1961)).
- the amino sequence of the amino terminus of the decarbamylase protein was determined.
- the enzyme solution was desalted using a Centricon-10 microcentrifuge (manufactured by Amicon), charged to a pulse-type liquid phase protein sequencer, and analyzed.
- the sequence of the amino terminus of the decarbamylase protein was
- a 17P-4 strain We searched for an enzyme-enhancing substance that increases the production of decarbamylase when culturing Blastobacter sp. A 17P-4 strain.
- the compound shown in FIG. 7 was added to the same medium D as used in Example 4 in 0.1 S ⁇ CwZ.
- Example 4 HPLC was used to determine the amount of D-HPG produced at a reaction temperature of only 40 ° C, and as shown in Fig. 7, when peracyl, dihydrouracil or; 5-peridopropionic acid was added, decarbamylase was added. Was found to increase production.
- 0.15% (wZV) of peracil was added to medium D, and the metal ions shown in Fig. 8 were added at a concentration of 2 mM, and this medium was inoculated. After shaking at 28 ° C for 4 days. Then, when the generated D—HPG was quantified, as shown in FIG. 8, Fe 2+ , Fe 3+ , Li +, Cs ⁇ Be 2+ , Mg 2+ , Mn 2+ , Co 2+ , Al 3+ It was found that the addition of such ions increases the production of decarbamylase.
- the enzyme solution (41 ml) was dialyzed against 51 of the above buffer solutions for 12 hours, and purified using a DE A ⁇ -Sephacel column and a Fenu-Sepharose CL-16B column according to the method described in Example ⁇ . Concentrated by filtration. Separate this concentrated solution (3 ml) in the above buffer containing 0.2 M NaCl. Gel filtration was performed using a Dex G-150 column ( ⁇ 1.580 cm), the active fraction was desalted by dialysis, and purified using a mono QHR55 column according to the method described in Example 5 to obtain an active fraction. (2 ml) was used for analysis as a purified enzyme solution. As a result of the above purification operation, as shown in Table 3, the specific activity was improved 37-fold compared to the cell lysate supernatant, and the enzyme activity recovery rate at that time was 2.3% .c
- Example 9 Using an enzyme solution obtained in Example 9 were examined blast Park coater sp. A17P- 4 optimum reaction P H and the optimum reaction temperature of deca Rubamiraze. In each case, the reaction was performed according to the method described in Example 6. These results are shown in FIGS. 11 and 12. The optimum pH of Blastobacter sp. A 17p-4 decarbamylase was 9 and the optimum reaction temperature was 50 ° C.
- Table for Rizobiumu genus and Brady Rizobiumu genus strains 7 strains of 4, 805 liquid medium 1 ml (yeast extract lg / l, mannitol 5g / l, K 2 H P0 4 0.7g / l, KH 2 P0 4 0. 1 g / Mg S0 4 ⁇ 7H 2 0 lg / l, C -D-HPG lg / 1 (pH7.0)) to the medium supplemented with C one D-HPG or C one D-Ala in a final concentration of 1 g / 1
- the cells were inoculated and cultured with shaking at 30 ° C for 24 hours.
- the bacteria are collected by centrifugation and suspended in 0.5 ml of 1% CD-HPG or C-D-Ala, 0.1 MK-phosphate buffer (pH 7.0), 0.1% triton X-100. It became cloudy. After reacting for 24 hours while shaking at 37 ° C, analysis was performed by thin-layer chromatography according to the method described in Example 1. As shown in Table 4, it was found that the strain of Bradyrhizobium had weakened rubamil activity.
- Soil was further screened by the method described in Example 1. Screening was performed for N-forced Lubamil-D-mouth isine (C-D-Leu), N-forced Lubamil-D-alanine (C-D-Ala), N-forced Lubamil-D-phenylglycine (C-D- PG) or DL-5-methylhydantoin (DL-Ala-hyd) was used as a carbon source or a nitrogen source. As in Example 12, the weakened rubamil activity was examined using CD-Ala and CD-HPG for 9 of the grown bacteria. As shown in Table 5, as shown in Table 5, there were a strain having higher activity against CD-HPG and a strain having higher activity against CD-Ala.
- the rhizobime sp.KNK1415 obtained in Example 3 was added to 101 SE medium (sucrose 23 g 1, yeast extract 4 gZl, urea 2 gZl, KH 2 P0 4 2 g / Na 2 HPO 4 2 1, was inoculated into MgS 0 4 ⁇ 7 H 2 0 1 g / 1, MnCl 2 ⁇ 4H 2 0 0.0 lg / l (pH6.5)), at 30 ° C
- the cells were cultured with shaking for 40 hours. The cells were collected by centrifugation, washed with 0.9% saline, disrupted by ultrasonic waves, and the residue was removed by centrifugation.
- the nucleic acid was removed by protamine sulfate treatment (0.1 mg Zmg protein). Then, the centrifuged supernatant was heat-treated at 50 ° C for 30 minutes, and the denatured protein was removed by centrifugation, and ammonium sulfate was added to achieve 30% saturation. The precipitate is collected by centrifugation, dissolved in 500 ml of 2 OmM TrisHC1 (pH 7.5), 2 mM DTT, dialyzed against the same buffer, adsorbed on a DEAE cellulose column, and 10 mM Na-phosphate buffer. (PH 7.2), eluted with 0.15 M NaCl, and lmM DTT. The eluate was concentrated by ultrafiltration using a YM-10 membrane (Amicon). When this enzyme solution was analyzed by SDS-polyacrylamide gel electrophoresis, this decarbamylase was electrophoresed at around 35,000.
- the gel of the decarbamylase band was cut out from the SDS-polyacrylamide gel obtained by analyzing the decarbamylase obtained in Example 14, and the elution buffer (5 OmM Tris-HCl (pH 7.5), 0.1% SDS, 0.1% ImM EDTA , 15 OmM NaCl, 5 mM DTT) and eluted at room temperature.
- the extract was concentrated by ultrafiltration, charged to a reversed-phase HPLC column (AP-303; manufactured by YMC), and eluted with an acetonitrile concentration gradient.
- the fraction containing decarbamylase was charged to a gas-phase protein sequencer (manufactured by Applied Biosystems) and analyzed. 1 5 10
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP93921099A EP0628637B1 (en) | 1992-10-05 | 1993-10-01 | Process for producing d-alpha-amino acids |
US08/244,657 US5902736A (en) | 1992-10-05 | 1993-10-01 | Process for the production of D-α-amino acids by hydrolysis of the corresponding N-carbamyl derivative |
DE69330343T DE69330343T2 (de) | 1992-10-05 | 1993-10-01 | Verfahren zur herstellung von d-alpha-aminosäuren |
KR1020007013779A KR100328111B1 (ko) | 1992-10-05 | 1993-10-01 | 데카르바밀라제의 제조방법 |
KR1019940701912A KR100293585B1 (ko) | 1992-10-05 | 1993-10-01 | D-알파-아미노산의제조방법 |
US08/479,639 US5863785A (en) | 1992-10-05 | 1995-06-07 | Decarbamylase isolated from comamonas or blastobacter |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP26591492 | 1992-10-05 | ||
JP4/265914 | 1992-10-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1994008030A1 true WO1994008030A1 (en) | 1994-04-14 |
Family
ID=17423857
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1993/001408 WO1994008030A1 (en) | 1992-10-05 | 1993-10-01 | PROCESS FOR PRODUCING D-α-AMINO ACID |
Country Status (8)
Country | Link |
---|---|
US (2) | US5902736A (ja) |
EP (1) | EP0628637B1 (ja) |
KR (2) | KR100293585B1 (ja) |
CN (2) | CN1048524C (ja) |
DE (1) | DE69330343T2 (ja) |
ES (1) | ES2159527T3 (ja) |
SG (1) | SG55164A1 (ja) |
WO (1) | WO1994008030A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5962279A (en) * | 1994-06-24 | 1999-10-05 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Process for producing D-amino acids with composite immobilized enzyme preparation |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5718793B2 (ja) * | 1978-12-27 | 1982-04-19 | ||
JPH0148758B2 (ja) * | 1986-07-19 | 1989-10-20 | Kanegafuchi Chemical Ind |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4211840A (en) * | 1977-06-08 | 1980-07-08 | Ajinomoto Company, Incorporated | Method for producing D-α-amino acid |
JPS557001A (en) * | 1978-03-15 | 1980-01-18 | Kanegafuchi Chem Ind Co Ltd | Preparation of n-carbamoyl-d-thienylglycine |
IT1109506B (it) * | 1978-05-23 | 1985-12-16 | Snam Progetti | Processo enzimatico-microbiologico per la produzione di amminoacidi otticamente attivi a partire da idantoine e/o carbamil-derivati racemi |
JPS5718793A (en) * | 1980-07-08 | 1982-01-30 | Kao Corp | Granulation of coal-water slurry |
DE3031151A1 (de) * | 1980-08-18 | 1982-04-15 | Basf Ag, 6700 Ludwigshafen | Verfahren zur herstellung von d-n-carbamoyl-(alpha)-aminosaeuren und mikroorganismen dafuer |
JPS619292A (ja) * | 1984-06-25 | 1986-01-16 | Denki Kagaku Kogyo Kk | L−アミノ酸の製造方法 |
JPS6448758A (en) * | 1987-08-20 | 1989-02-23 | Canon Kk | Recorder |
JPS6471477A (en) * | 1987-09-11 | 1989-03-16 | Nippon Soda Co | Microbial strain capable of producing l-amino acid |
ES2121001T3 (es) * | 1990-12-07 | 1998-11-16 | Kanegafuchi Chemical Ind | Procedimiento de produccion de d-alfa aminoacidos. |
JP3438890B2 (ja) * | 1992-08-10 | 2003-08-18 | 鐘淵化学工業株式会社 | 耐熱性の向上したデカルバミラーゼをコードするdnaおよびその用途 |
-
1993
- 1993-10-01 DE DE69330343T patent/DE69330343T2/de not_active Expired - Fee Related
- 1993-10-01 KR KR1019940701912A patent/KR100293585B1/ko not_active IP Right Cessation
- 1993-10-01 EP EP93921099A patent/EP0628637B1/en not_active Expired - Lifetime
- 1993-10-01 WO PCT/JP1993/001408 patent/WO1994008030A1/ja active IP Right Grant
- 1993-10-01 ES ES93921099T patent/ES2159527T3/es not_active Expired - Lifetime
- 1993-10-01 KR KR1020007013779A patent/KR100328111B1/ko not_active IP Right Cessation
- 1993-10-01 US US08/244,657 patent/US5902736A/en not_active Expired - Fee Related
- 1993-10-01 SG SG1996008489A patent/SG55164A1/en unknown
- 1993-10-05 CN CN93114421A patent/CN1048524C/zh not_active Expired - Fee Related
- 1993-10-05 CN CNB981237320A patent/CN1187444C/zh not_active Expired - Fee Related
-
1995
- 1995-06-07 US US08/479,639 patent/US5863785A/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5718793B2 (ja) * | 1978-12-27 | 1982-04-19 | ||
JPH0148758B2 (ja) * | 1986-07-19 | 1989-10-20 | Kanegafuchi Chemical Ind |
Non-Patent Citations (1)
Title |
---|
See also references of EP0628637A4 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5962279A (en) * | 1994-06-24 | 1999-10-05 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Process for producing D-amino acids with composite immobilized enzyme preparation |
Also Published As
Publication number | Publication date |
---|---|
ES2159527T3 (es) | 2001-10-16 |
EP0628637A4 (en) | 1997-03-05 |
CN1221793A (zh) | 1999-07-07 |
KR100328111B1 (ko) | 2002-03-09 |
DE69330343D1 (de) | 2001-07-19 |
SG55164A1 (en) | 1998-12-21 |
CN1048524C (zh) | 2000-01-19 |
US5902736A (en) | 1999-05-11 |
DE69330343T2 (de) | 2002-05-02 |
CN1187444C (zh) | 2005-02-02 |
EP0628637A1 (en) | 1994-12-14 |
US5863785A (en) | 1999-01-26 |
EP0628637B1 (en) | 2001-06-13 |
KR100293585B1 (ko) | 2001-09-17 |
CN1102672A (zh) | 1995-05-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100247853B1 (ko) | D-알파-아미노산의 제조방법 | |
AU643758B2 (en) | Novel esterase and process for preparing the same | |
HU202918B (en) | Process for producing acidic urease | |
JPH0665300B2 (ja) | フルクトシルアミノ酸オキシダーゼ | |
JP3014171B2 (ja) | 4−ハロ−3−ヒドロキシブチルアミドの製造法 | |
JPS6322188A (ja) | 新規なl−アミノアシラ−ゼ | |
WO1994008030A1 (en) | PROCESS FOR PRODUCING D-α-AMINO ACID | |
JP3415218B2 (ja) | D−α−アミノ酸の製造法 | |
JP4300289B2 (ja) | 加水分解又は脱水縮合酵素、及び当該酵素の生産方法、並びに当該酵素を用いたアミドの合成方法 | |
EP0892044A2 (en) | Esterase and its use for the production of optically active chroman compounds | |
US4918012A (en) | Method for producing carnitine, L-carnitinamide hydrolase and method for producing same | |
JPH0783711B2 (ja) | 新規なd―アミノアシラーゼの製造法 | |
JPH0822228B2 (ja) | アミノ酸アミド加水分解酵素及びその使用 | |
JP2712331B2 (ja) | アシルアミノ酸ラセマーゼ、その製造法および用途 | |
JPS5840473B2 (ja) | 新規なプロリンアシラ−ゼ及びその製法 | |
JP2983695B2 (ja) | 4−ハロ−3−ヒドロキシ酪酸の製造法 | |
JP3090761B2 (ja) | 光学活性乳酸の製造法 | |
JP2840723B2 (ja) | 4‐ハロ‐3‐ヒドロキシブチロニトリルの製造法 | |
JPS6319158B2 (ja) | ||
JP3824244B2 (ja) | コレステロール・エステラーゼの製造方法 | |
JPH0614772A (ja) | 新規エステル分解酵素aおよびその製造方法 | |
JP3820617B2 (ja) | ε−ポリ−L−リシン分解酵素とそれを用いた低重合度ε−ポリ−L−リシンの製造法 | |
WO1986000925A1 (en) | Process for preparing lipase | |
JPH09107959A (ja) | リンゴ酸脱水素酵素及びその製造方法 | |
JP2812481B2 (ja) | 新規なエステラーゼおよびその製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): KR US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1019940701912 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 08244657 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1993921099 Country of ref document: EP |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWP | Wipo information: published in national office |
Ref document number: 1993921099 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020007013779 Country of ref document: KR |
|
WWG | Wipo information: grant in national office |
Ref document number: 1993921099 Country of ref document: EP |